Last 12 months
Inside the activity.
0 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 24, 2021 Filed Feb 26, 2021 21:31 UTC |
McCallion John D.EVP & Chief Financial Officer
|
SaleCommon Stock | 7,742 | $59.52 | $460,775.97 |
DisclosureSEC source: 0001099219-21-000077 · wf-form4_161437503217390.xml · nonDerivative · entry 2 McCallion John D. · CIK 0001709116 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,436 F1 · shares: Sale to pay option exercise price and related tax obligations and fees. F2 · price: The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The shares were sold at prices $59.515 to $59.52, inclusive. The reporting person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 21:31 UTC |
McCallion John D.EVP & Chief Financial Officer
|
Exercise / conversionCommon Stock | 10,745 | $34.21 | $367,586.45 |
DisclosureSEC source: 0001099219-21-000077 · wf-form4_161437503217390.xml · nonDerivative · entry 1 McCallion John D. · CIK 0001709116 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,178 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:35 UTC |
Lee EstherEVP - Gl. Chief Marketing Off.
|
GrantEmployee Stock Options (right to buy) · Derivative | 9,797 | $0.00 Strike: $57.43 | $0.00 |
DisclosureSEC source: 0001099219-21-000074 · wf-form4_161429246914206.xml · derivative · entry 4 Lee Esther · CIK 0001585015 · EVP - Gl. Chief Marketing Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,797 Underlying: Common Stock · 9,797 shares Expires 2031-02-22 F5 · derivative.exercise_date: The options become exercisable in equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:35 UTC |
Lee EstherEVP - Gl. Chief Marketing Off.
|
Tax withholdingCommon Stock | 8,293 | $57.43 | $476,266.99 |
DisclosureSEC source: 0001099219-21-000074 · wf-form4_161429246914206.xml · nonDerivative · entry 3 Lee Esther · CIK 0001585015 · EVP - Gl. Chief Marketing Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,519 F4 · kind: Shares withheld to satisfy the reporting person's tax withholding obligation due on the performance share payout. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:35 UTC |
Lee EstherEVP - Gl. Chief Marketing Off.
|
GrantCommon Stock | 20,455 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-21-000074 · wf-form4_161429246914206.xml · nonDerivative · entry 2 Lee Esther · CIK 0001585015 · EVP - Gl. Chief Marketing Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,812 F3 · price: Shares acquired from the determination of the performance factor for and payout of 2018-2020 performance shares under the MetLife, Inc. 2015 Stock and Incentive Compensation. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:35 UTC |
Lee EstherEVP - Gl. Chief Marketing Off.
|
GrantCommon Stock | 3,265 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-21-000074 · wf-form4_161429246914206.xml · nonDerivative · entry 1 Lee Esther · CIK 0001585015 · EVP - Gl. Chief Marketing Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,357 F1 · price: Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. F2 · balance_after: Includes 7,948 restricted stock units previously reported on Table II. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:35 UTC |
DEBEL MARLENEEVP & Chief Risk Officer
|
GrantEmployee Stock Options (right to buy) · Derivative | 15,674 | $0.00 Strike: $57.43 | $0.00 |
DisclosureSEC source: 0001099219-21-000075 · wf-form4_161429251319284.xml · derivative · entry 4 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,674 Underlying: Common Stock · 15,674 shares Expires 2031-02-22 F5 · derivative.exercise_date: The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:35 UTC |
DEBEL MARLENEEVP & Chief Risk Officer
|
Tax withholdingCommon Stock | 2,708 | $57.43 | $155,520.44 |
DisclosureSEC source: 0001099219-21-000075 · wf-form4_161429251319284.xml · nonDerivative · entry 3 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,471 F4 · kind: Shares withheld to satisfy the reporting person's tax withholding obligation due on the performance share payout. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:35 UTC |
DEBEL MARLENEEVP & Chief Risk Officer
|
GrantCommon Stock | 7,914 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-21-000075 · wf-form4_161429251319284.xml · nonDerivative · entry 2 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,179 F3 · price: Shares acquired from the determination of the performance factor for and payout of 2018-2020 performance shares under the MetLife, Inc. 2015 Stock and Incentive Compensation. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:35 UTC |
DEBEL MARLENEEVP & Chief Risk Officer
|
GrantCommon Stock | 5,224 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-21-000075 · wf-form4_161429251319284.xml · nonDerivative · entry 1 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,265 F1 · price: Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. F2 · balance_after: Includes 8,275 restricted stock units previously reported on Table II. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:34 UTC |
GAUSTER STEPHEN WEVP & General Counsel
|
GrantEmployee Stock Options (right to buy) · Derivative | 11,756 | $0.00 Strike: $57.43 | $0.00 |
DisclosureSEC source: 0001099219-21-000073 · wf-form4_161429242024489.xml · derivative · entry 4 GAUSTER STEPHEN W · CIK 0001709219 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,756 Underlying: Common Stock · 11,756 shares Expires 2031-02-22 F5 · derivative.exercise_date: The options become exercisable in sustainably equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:34 UTC |
GAUSTER STEPHEN WEVP & General Counsel
|
Tax withholdingCommon Stock | 2,352 | $57.43 | $135,075.36 |
DisclosureSEC source: 0001099219-21-000073 · wf-form4_161429242024489.xml · nonDerivative · entry 3 GAUSTER STEPHEN W · CIK 0001709219 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,477 F4 · kind: Shares withheld to satisfy the reporting person's tax withholding obligation due on the performance share payout. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:34 UTC |
GAUSTER STEPHEN WEVP & General Counsel
|
GrantCommon Stock | 6,088 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-21-000073 · wf-form4_161429242024489.xml · nonDerivative · entry 2 GAUSTER STEPHEN W · CIK 0001709219 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,829 F3 · price: Shares acquired from the determination of the performance factor for and payout of 2018-2020 performance shares under the MetLife, Inc. 2015 Stock and Incentive Compensation. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:34 UTC |
GAUSTER STEPHEN WEVP & General Counsel
|
GrantCommon Stock | 3,918 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-21-000073 · wf-form4_161429242024489.xml · nonDerivative · entry 1 GAUSTER STEPHEN W · CIK 0001709219 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,741 F1 · price: Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. F2 · balance_after: Includes 8,776 restricted stock units previously reported on Table II. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:33 UTC |
SCHOCK TAMARAEVP & Chief Accounting Officer
|
GrantEmployee Stock Options (right to buy) · Derivative | 7,707 | $0.00 Strike: $57.43 | $0.00 |
DisclosureSEC source: 0001099219-21-000072 · wf-form4_161429239181483.xml · derivative · entry 2 SCHOCK TAMARA · CIK 0001761331 · EVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,707 Underlying: Common Stock · 7,707 shares Expires 2031-02-22 F3 · derivative.exercise_date: The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:33 UTC |
SCHOCK TAMARAEVP & Chief Accounting Officer
|
GrantCommon Stock | 2,569 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-21-000072 · wf-form4_161429239181483.xml · nonDerivative · entry 1 SCHOCK TAMARA · CIK 0001761331 · EVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,223 F1 · price: Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. F2 · balance_after: Includes 9,654 restricted stock units previously reported on Table II. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:33 UTC |
PODLOGAR SUSAN MEVP & Chief HR Officer
|
GrantEmployee Stock Options (right to buy) · Derivative | 11,756 | $0.00 Strike: $57.43 | $0.00 |
DisclosureSEC source: 0001099219-21-000071 · wf-form4_161429237341434.xml · derivative · entry 4 PODLOGAR SUSAN M · CIK 0001709959 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,756 Underlying: Common Stock · 11,756 shares Expires 2031-02-22 F5 · derivative.exercise_date: The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:33 UTC |
PODLOGAR SUSAN MEVP & Chief HR Officer
|
Tax withholdingCommon Stock | 2,934 | $57.43 | $168,499.62 |
DisclosureSEC source: 0001099219-21-000071 · wf-form4_161429237341434.xml · nonDerivative · entry 3 PODLOGAR SUSAN M · CIK 0001709959 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,633 F4 · kind: Shares withheld to satisfy the reporting person's tax withholding obligation due on the performance share payout. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:33 UTC |
PODLOGAR SUSAN MEVP & Chief HR Officer
|
GrantCommon Stock | 8,523 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-21-000071 · wf-form4_161429237341434.xml · nonDerivative · entry 2 PODLOGAR SUSAN M · CIK 0001709959 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,567 F3 · price: Shares acquired from the determination of the performance factor for and payout of 2018-2020 performance shares under the MetLife, Inc. 2015 Stock and Incentive Compensation. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:33 UTC |
PODLOGAR SUSAN MEVP & Chief HR Officer
|
GrantCommon Stock | 3,918 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-21-000071 · wf-form4_161429237341434.xml · nonDerivative · entry 1 PODLOGAR SUSAN M · CIK 0001709959 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,044 F1 · price: Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. F2 · balance_after: Includes 7,337 restricted stock units previously reported on Table II. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:32 UTC |
Goulart Steven JEVP & Chief Investment Officer
|
GrantEmployee Stock Options (right to buy) · Derivative | 31,348 | $0.00 Strike: $57.43 | $0.00 |
DisclosureSEC source: 0001099219-21-000070 · wf-form4_161429234535327.xml · derivative · entry 4 Goulart Steven J · CIK 0001519833 · EVP & Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,348 Underlying: Common Stock · 31,348 shares Expires 2031-02-22 F5 · derivative.exercise_date: The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:32 UTC |
Goulart Steven JEVP & Chief Investment Officer
|
Tax withholdingCommon Stock | 23,762 | $57.43 | $1,364,651.66 |
DisclosureSEC source: 0001099219-21-000070 · wf-form4_161429234535327.xml · nonDerivative · entry 3 Goulart Steven J · CIK 0001519833 · EVP & Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,544 F4 · kind: Shares withheld to satisfy the reporting person's tax withholding obligation due on the performance share payout. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:32 UTC |
Goulart Steven JEVP & Chief Investment Officer
|
GrantCommon Stock | 51,138 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-21-000070 · wf-form4_161429234535327.xml · nonDerivative · entry 2 Goulart Steven J · CIK 0001519833 · EVP & Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,306 F3 · price: Shares acquired from the determination of the performance factor for and payout of 2018-2020 performance shares under the MetLife, Inc. 2015 Stock and Incentive Compensation. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:32 UTC |
Goulart Steven JEVP & Chief Investment Officer
|
GrantCommon Stock | 10,448 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-21-000070 · wf-form4_161429234535327.xml · nonDerivative · entry 1 Goulart Steven J · CIK 0001519833 · EVP & Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,168 F1 · price: Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. F2 · balance_after: Includes 24,867 restricted stock units previously reported on Table II. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:32 UTC |
Khalaf MichelDirector · President & CEO
|
GrantEmployee Stock Options (right to buy) · Derivative | 90,126 | $0.00 Strike: $57.43 | $0.00 |
DisclosureSEC source: 0001099219-21-000069 · wf-form4_161429230444999.xml · derivative · entry 4 Khalaf Michel · CIK 0001535491 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,126 Underlying: Common Stock · 90,126 shares Expires 2031-02-22 F5 · derivative.exercise_date: The options become exercisable in equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:32 UTC |
Khalaf MichelDirector · President & CEO
|
Tax withholdingCommon Stock | 29,141 | $57.43 | $1,673,567.63 |
DisclosureSEC source: 0001099219-21-000069 · wf-form4_161429230444999.xml · nonDerivative · entry 3 Khalaf Michel · CIK 0001535491 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,271 F4 · kind: Shares withheld to satisfy the reporting person's tax withholding obligation due on the performance share payout. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:32 UTC |
Khalaf MichelDirector · President & CEO
|
GrantCommon Stock | 59,662 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-21-000069 · wf-form4_161429230444999.xml · nonDerivative · entry 2 Khalaf Michel · CIK 0001535491 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,412 F3 · price: Shares acquired from the determination of the performance factor for and payout of 2018-2020 performance shares under the MetLife, Inc. 2015 Stock and Incentive Compensation. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:32 UTC |
Khalaf MichelDirector · President & CEO
|
GrantCommon Stock | 30,037 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-21-000069 · wf-form4_161429230444999.xml · nonDerivative · entry 1 Khalaf Michel · CIK 0001535491 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,750 F1 · price: Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. F2 · balance_after: Includes 55,531 restricted stock units previously reported on Table II. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:31 UTC |
McCallion John D.EVP & Chief Financial Officer
|
GrantEmployee Stock Options (right to buy) · Derivative | 31,348 | $0.00 Strike: $57.43 | $0.00 |
DisclosureSEC source: 0001099219-21-000068 · wf-form4_161429224834746.xml · derivative · entry 4 McCallion John D. · CIK 0001709116 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,348 Underlying: Common Stock · 31,348 shares Expires 2031-02-22 F5 · derivative.exercise_date: The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:31 UTC |
McCallion John D.EVP & Chief Financial Officer
|
Tax withholdingCommon Stock | 2,711 | $57.43 | $155,692.73 |
DisclosureSEC source: 0001099219-21-000068 · wf-form4_161429224834746.xml · nonDerivative · entry 3 McCallion John D. · CIK 0001709116 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,433 F4 · kind: Shares withheld to satisfy the reporting person's tax withholding obligation due on the performance share payout. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:31 UTC |
McCallion John D.EVP & Chief Financial Officer
|
GrantCommon Stock | 7,914 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-21-000068 · wf-form4_161429224834746.xml · nonDerivative · entry 2 McCallion John D. · CIK 0001709116 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,144 F3 · price: Shares acquired from the determination of the performance factor for and payout of 2018-2020 performance shares under the MetLife, Inc. 2015 Stock and Incentive Compensation. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:31 UTC |
McCallion John D.EVP & Chief Financial Officer
|
GrantCommon Stock | 10,448 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-21-000068 · wf-form4_161429224834746.xml · nonDerivative · entry 1 McCallion John D. · CIK 0001709116 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,230 F1 · price: Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. F2 · balance_after: Includes 19,261 restricted stock units previously reported on Table II. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:30 UTC |
Ponnavolu KishorePresident, Asia
|
GrantEmployee Stock Options (right to buy) · Derivative | 16,458 | $0.00 Strike: $57.43 | $0.00 |
DisclosureSEC source: 0001099219-21-000067 · wf-form4_161429221296321.xml · derivative · entry 4 Ponnavolu Kishore · CIK 0001751468 · President, Asia 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,458 Underlying: Common Stock · 16,458 shares Expires 2031-02-22 F5 · derivative.exercise_date: The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:30 UTC |
Ponnavolu KishorePresident, Asia
|
Tax withholdingCommon Stock | 3,020 | $57.43 | $173,438.60 |
DisclosureSEC source: 0001099219-21-000067 · wf-form4_161429221296321.xml · nonDerivative · entry 3 Ponnavolu Kishore · CIK 0001751468 · President, Asia 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,981 F4 · kind: Shares withheld to satisfy the reporting person's tax withholding obligation due on the performance share payout. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:30 UTC |
Ponnavolu KishorePresident, Asia
|
GrantCommon Stock | 6,696 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-21-000067 · wf-form4_161429221296321.xml · nonDerivative · entry 2 Ponnavolu Kishore · CIK 0001751468 · President, Asia 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,001 F3 · price: Shares acquired from the determination of the performance factor for and payout of 2018-2020 performance shares under the MetLife, Inc. 2015 Stock and Incentive Compensation. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:30 UTC |
Ponnavolu KishorePresident, Asia
|
GrantCommon Stock | 5,485 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-21-000067 · wf-form4_161429221296321.xml · nonDerivative · entry 1 Ponnavolu Kishore · CIK 0001751468 · President, Asia 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,305 F1 · price: Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. F2 · balance_after: Includes 9,371 restricted stock units previously reported on Table II. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:30 UTC |
PAPPAS BILLEVP, Global Tech. & Ops.
|
GrantEmployee Stock Options (right to buy) · Derivative | 27,430 | $0.00 Strike: $57.43 | $0.00 |
DisclosureSEC source: 0001099219-21-000066 · wf-form4_161429219284688.xml · derivative · entry 2 PAPPAS BILL · CIK 0001787586 · EVP, Global Tech. & Ops. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,430 Underlying: Common Stock · 27,430 shares Expires 2031-02-22 F3 · derivative.exercise_date: The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:30 UTC |
PAPPAS BILLEVP, Global Tech. & Ops.
|
GrantCommon Stock | 9,142 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-21-000066 · wf-form4_161429219284688.xml · nonDerivative · entry 1 PAPPAS BILL · CIK 0001787586 · EVP, Global Tech. & Ops. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,856 F1 · price: Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. F2 · balance_after: Includes 93,370 restricted stock units previously reported on Table II. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:29 UTC |
TADROS RAMYPresident, U.S. Business
|
GrantEmployee Stock Options (right to buy) · Derivative | 27,430 | $0.00 Strike: $57.43 | $0.00 |
DisclosureSEC source: 0001099219-21-000065 · wf-form4_161429215052708.xml · derivative · entry 4 TADROS RAMY · CIK 0001714199 · President, U.S. Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,430 Underlying: Common Stock · 27,430 shares Expires 2031-02-22 F5 · derivative.exercise_date: The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:29 UTC |
TADROS RAMYPresident, U.S. Business
|
Tax withholdingCommon Stock | 3,900 | $57.43 | $223,977.00 |
DisclosureSEC source: 0001099219-21-000065 · wf-form4_161429215052708.xml · nonDerivative · entry 3 TADROS RAMY · CIK 0001714199 · President, U.S. Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,334 F4 · kind: Shares withheld to satisfy the reporting person's tax withholding obligation due on the performance share payout. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:29 UTC |
TADROS RAMYPresident, U.S. Business
|
GrantCommon Stock | 10,227 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-21-000065 · wf-form4_161429215052708.xml · nonDerivative · entry 2 TADROS RAMY · CIK 0001714199 · President, U.S. Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,234 F3 · price: Shares acquired from the determination of the performance factor for and payout of 2018-2020 performance shares under the MetLife, Inc. 2015 Stock and Incentive Compensation. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:29 UTC |
TADROS RAMYPresident, U.S. Business
|
GrantCommon Stock | 9,142 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-21-000065 · wf-form4_161429215052708.xml · nonDerivative · entry 1 TADROS RAMY · CIK 0001714199 · President, U.S. Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,007 F1 · price: Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. F2 · balance_after: Includes 14,598 restricted stock units previously reported on Table II. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 21:35 UTC |
Goulart Steven JEVP & Chief Investment Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 20,484 | $0.00 Strike: $40.91 | $0.00 |
DisclosureSEC source: 0001099219-21-000053 · wf-form4_161402971239732.xml · derivative · entry 3 Goulart Steven J · CIK 0001519833 · EVP & Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,484 shares Expires 2021-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Includes 2,184 stock options previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the stock options in light of the distribution by MetLife, Inc. to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the stock options. F4 · derivative.exercise_date: The options became exercisable in three substantially equal installments on February 23, 2012, 2013 and 2014. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 21:35 UTC |
Goulart Steven JEVP & Chief Investment Officer
|
SaleCommon Stock | 17,055 | $54.94 | $937,003.41 |
DisclosureSEC source: 0001099219-21-000053 · wf-form4_161402971239732.xml · nonDerivative · entry 2 Goulart Steven J · CIK 0001519833 · EVP & Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,853 F1 · shares: The reporting person sold only the number of shares of MetLife, Inc.'s common stock necessary to pay the exercise price of the options exercised on February 18, 2021 and related tax obligations and fees. F2 · price: The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The shares were sold at prices $54.93 to $54.97, inclusive. The reporting person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 21:35 UTC |
Goulart Steven JEVP & Chief Investment Officer
|
Exercise / conversionCommon Stock | 20,484 | $40.91 | $838,000.44 |
DisclosureSEC source: 0001099219-21-000053 · wf-form4_161402971239732.xml · nonDerivative · entry 1 Goulart Steven J · CIK 0001519833 · EVP & Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,908 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 05, 2021 Filed Feb 8, 2021 23:06 UTC |
McCallion John D.EVP & Chief Financial Officer
|
Exercise / conversionEmployee Stock Options (right to buy) · Derivative | 8,619 | $0.00 Strike: $40.91 | $0.00 |
DisclosureSEC source: 0001099219-21-000039 · wf-form4_161282554814553.xml · derivative · entry 3 McCallion John D. · CIK 0001709116 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,619 shares Expires 2021-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options became exercisable in three substantially equal installments on February 23, 2012, 2013 and 2014. Read SEC document |
| February 05, 2021 Filed Feb 8, 2021 23:06 UTC |
McCallion John D.EVP & Chief Financial Officer
|
SaleCommon Stock | 7,456 | $52.22 | $389,315.04 |
DisclosureSEC source: 0001099219-21-000039 · wf-form4_161282554814553.xml · nonDerivative · entry 2 McCallion John D. · CIK 0001709116 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,521 F1 · shares: The reporting person sold only the number of shares of MetLife, Inc.'s common stock necessary to pay the exercise price of the options exercised on February 5, 2021 and related tax obligations and fees. Read SEC document |
| February 05, 2021 Filed Feb 8, 2021 23:06 UTC |
McCallion John D.EVP & Chief Financial Officer
|
Exercise / conversionCommon Stock | 8,619 | $40.91 | $352,603.29 |
DisclosureSEC source: 0001099219-21-000039 · wf-form4_161282554814553.xml · nonDerivative · entry 1 McCallion John D. · CIK 0001709116 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,977 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 21:33 UTC |
WEINBERGER MARK ADirector
|
GrantCommon Stock | 814 | $46.08 | $37,509.12 |
DisclosureSEC source: 0001099219-21-000033 · wf-form4_160988237622708.xml · nonDerivative · entry 1 WEINBERGER MARK A · CIK 0001785997 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,922 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 21:32 UTC |
MORRISON DENISE MDirector
|
GrantCommon Stock | 814 | $46.08 | $37,509.12 |
DisclosureSEC source: 0001099219-21-000032 · wf-form4_160988234947230.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,832 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.